Neoadjuvant targeted therapies in renal cell carcinoma

被引:0
作者
Vincenzo Ficarra
Giacomo Novara
机构
[1] Urology Clinic,Department of Oncological and Surgical Sciences
[2] University of Padua,undefined
[3] Monoblocco Ospedaliero–IV Floor,undefined
来源
Nature Reviews Urology | 2010年 / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Neoadjuvant targeted therapy can be used in patients with unresectable locally advanced, locally recurrent or metastatic renal cell carcinoma to induce cytoreduction before surgical resection. The efficacy of this multimodal therapy is still unproven, however, and must be balanced against a potential higher risk of perioperative complications.
引用
收藏
页码:63 / 64
页数:1
相关论文
共 10 条
[1]  
Thomas AA(2009)Surgical resection of renal cell carcinoma after targeted therapy J. Urol. 182 881-886
[2]  
Flanigan RC(2004)Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis J. Urol. 171 1071-1076
[3]  
Motzer RJ(2007)Sunitinib versus interferon alfa in metastatic renal-cell carcinoma N. Engl. J. Med. 356 115-124
[4]  
Hudes G(2007)Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma N. Engl. J. Med. 356 2271-2281
[5]  
Escudier B(2007)Sorafenib in advanced clear-cell renal-cell carcinoma N. Engl. J. Med. 356 125-134
[6]  
Amin C(2008)Preoperative tyrosine kinase inhibition as an adjunct to debulking nephrectomy Urology 72 864-868
[7]  
Bex A(2009)Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery World J. Urol. 27 533-539
[8]  
Karakiewicz PI(2008)Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi Eur. Urol. 53 845-848
[9]  
Shuch B(2008)Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm BJU Int. 102 692-696
[10]  
Margulis V(2008)Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma J. Urol. 180 94-98